Invivyd (IVVD) Change in Receivables (2024 - 2025)
Invivyd (IVVD) posted Change in Receivables of $4.1 million for Q4 2025, up 199.12% on a QoQ basis from $1.4 million in Q3 2025, and up 47.82% year-over-year from $2.8 million in Q4 2024.
Invivyd (IVVD) Change in Receivables (2024 - 2025) Analysis & Trends
Invivyd's Change in Receivables history runs 2 years deep, the most recent figure standing at $4.1 million for Q4 2025.
- Quarterly Change in Receivables rose 47.82% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (down 69.4% YoY) and the FY2025 annual result came in at $3.3 million, down 69.4% from the prior year.
- Change in Receivables was $4.1 million for Q4 2025 at Invivyd, up from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.3 million in Q3 2024 and bottomed at -$2.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 4.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.07 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 254,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | -2.35 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.89 Mn |